Bullish case
$65 to $85
More likely if EPS compounds near 10% annually through continued premium growth, benign credit conditions, steady new insurance written, efficient expense management, aggressive buybacks continue reducing share count by 3-5% annually, and investors value NMIH near 12x normalized earnings.